FDA product code LGI: Fluorescence Polarization Immunoassay, Carbamazepine

LGI is the FDA product code for fluorescence polarization immunoassay, carbamazepine. It is a Class II device, regulated under 21 CFR 862.3645 and reviewed by the Clinical Toxicology panel. FDA has cleared 3 510(k) submissions under LGI, from 3 different applicants. The average 510(k) review took 91 days (median 83). FDA has posted 4 recalls for LGI devices.

Classification

FieldValue
Device nameFluorescence Polarization Immunoassay, Carbamazepine
Device classClass II
Regulation21 CFR 862.3645
Review panelTX — Clinical Toxicology
Medical specialtyClinical Toxicology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every LGI clearance

Top LGI applicants

ApplicantClearancesLatest
Sigma Diagnostics, Inc.11994-11-10
Abbott Laboratories11994-06-21
Innotron of Oregon, Inc.11990-04-12

Most recent LGI clearances

510(k)ApplicantDeviceDecision dateReview days
K944063Sigma Diagnostics, Inc.FLUORESCENCE POLARIZATION IMMUNOASSAY CARBAMAZEPINE1994-11-1083
K940682Abbott LaboratoriesAXSYM(TM) QUINIDINE1994-06-21131
K900702Innotron of Oregon, Inc.MODIFIED ACCUFLUOR CARBAMAZEPINE REAGENT & CALIBRA1990-04-1259

Recalls for LGI devices

4 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2007-05-31.

Frequently asked questions

What is FDA product code LGI?

LGI is the FDA product code for fluorescence polarization immunoassay, carbamazepine. It is a Class II device, regulated under 21 CFR 862.3645 and reviewed by the Clinical Toxicology panel.

What device class is LGI?

Class II, regulation 21 CFR 862.3645. Typical premarket route: 510(k).

How long does a 510(k) take for product code LGI?

Across 3 cleared submissions the average was 91 days from receipt to decision (median 83).

Which companies have the most LGI clearances?

Sigma Diagnostics, Inc. (1); Abbott Laboratories (1); Innotron of Oregon, Inc. (1).

Have LGI devices been recalled?

Yes: 4 product recalls across 1 recall events; the most recent began 2007-05-31.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Toxicology product codes · FDA product code lookup · 510(k) database search · 510(k) review times